Growth Metrics

OptimizeRx (OPRX) Interest Expenses (2024 - 2026)

OptimizeRx's Interest Expenses history spans 6 years, with the latest figure at $1.2 million for Q4 2025.

  • On a quarterly basis, Interest Expenses fell 20.6% to $1.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $5.3 million, a 14.06% decrease, with the full-year FY2025 number at $5.3 million, down 14.06% from a year prior.
  • Interest Expenses hit $1.2 million in Q4 2025 for OptimizeRx, up from $1.2 million in the prior quarter.
  • Over the last five years, Interest Expenses for OPRX hit a ceiling of $1.6 million in Q2 2025 and a floor of $1.2 million in Q3 2025.